Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
MDxHealth SA
13D/A
Amendment 1
MDXH · 58286E102
|
32.0% |
10/15/2026
Event 10/13/2026
|
|||
| Bleichroeder LP | 32.0% | ||||
| Bleichroeder Holdings LLC | 32.0% | ||||
| Andrew Gundlach | 32.0% | ||||
|
Identiv, Inc. (INVE)
13D/A
Amendment 6
INVE · 45170X205
|
19.9% |
8/25/2026
Event 8/24/2026
|
|||
| Bleichroeder LP | 19.9% | ||||
| Bleichroeder Holdings LLC | 19.9% | ||||
| Andrew Gundlach | 19.9% | ||||
|
MDxHealth SA
13D
MDXH · 58286E102
|
33.2% |
8/14/2026
Event 8/11/2026
|
|||
| Bleichroeder LP | 33.2% | ||||
| Bleichroeder Holdings LLC | 33.2% | ||||
| Andrew Gundlach | 33.2% | ||||
|
Modular Medical, Inc
13G
MODD · 60785L306
|
6.2% |
8/13/2026
Event 6/30/2026
|
|||
| Bleichroeder LP | 6.2% | ||||
| Bleichroeder Holdings LLC | 6.2% | ||||
| Andrew Gundlach | 6.2% | ||||
|
Sintx Technologies Inc
13G
SINT · 829392703
|
10.0% |
8/13/2026
Event 6/30/2026
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
Guerrilla RF, Inc.
13G/A
Amendment 2
GUER · 40162G203
|
6.5% |
8/13/2026
Event 6/30/2026
|
|||
| Bleichroeder LP | 6.5% | ||||
| Bleichroeder Holdings LLC | 6.5% | ||||
| Andrew Gundlach | 6.5% | ||||
|
Fluent, Inc.
13G/A
Amendment 1
FLNT · 34380C201
|
8.2% |
8/13/2026
Event 6/30/2026
|
|||
| Bleichroeder LP | 8.2% | ||||
| Bleichroeder Holdings LLC | 8.2% | ||||
| Andrew Gundlach | 8.2% | ||||
|
Duos Technologies Group, Inc.
13G/A
Amendment 9
DUOT · 266042407
|
18.5% |
8/13/2026
Event 6/30/2026
|
|||
| Bleichroeder LP | 18.5% | ||||
| Bleichroeder Holdings LLC | 18.5% | ||||
| Andrew Gundlach | 18.5% | ||||
|
Cellectar Biosciences, Inc.
13G
CLRB · 15117F880
|
10.0% |
8/13/2026
Event 6/30/2026
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
First Eagle Real Estate Debt Fund
13D/A
Amendment 4
32009F100
|
41.0% |
7/9/2026
Event 7/7/2026
|
|||
| Bleichroeder LP | 41.0% | ||||
| Bleichroeder Holdings LLC | 41.0% | ||||
| Andrew Gundlach | 41.0% | ||||
|
Identiv, Inc. (INVE)
13D/A
Amendment 5
INVE · 45170X205
|
19.9% |
6/25/2026
Event 6/24/2026
|
|||
| Bleichroeder LP | 19.9% | ||||
| Bleichroeder Holdings LLC | 19.9% | ||||
| Andrew Gundlach | 19.9% | ||||
|
LiqTech International, Inc.
13D/A
Amendment 4
LIQT · 53632A300
|
20.9% |
6/9/2026
Event 6/5/2026
|
|||
| Bleichroeder LP | 20.9% | ||||
| Bleichroeder Holdings LLC | 20.9% | ||||
| Andrew Gundlach | 20.9% | ||||
|
LiqTech International, Inc.
13D/A
Amendment 3
LIQT · 53632A300
|
33.7% |
5/27/2026
Event 5/22/2026
|
|||
| Bleichroeder LP | 33.7% | ||||
| Bleichroeder Holdings LLC | 33.7% | ||||
| Andrew Gundlach | 33.7% | ||||
|
Envoy Medical, Inc.
13G
COCH · 29415V109
|
10.0% |
5/14/2026
Event 3/31/2026
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
Ernexa Therapeutics Inc.
13G
ERNA · 114082308
|
6.9% |
5/14/2026
Event 3/31/2026
|
|||
| Bleichroeder LP | 6.9% | ||||
| Bleichroeder Holdings LLC | 6.9% | ||||
| Andrew Gundlach | 6.9% | ||||
|
Barfresh Food Group Inc.
13G/A
Amendment 6
BRFH · 067532200
|
10.0% |
5/14/2026
Event 3/31/2026
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
Precision Biosciences Inc
13G/A
Amendment 1
DTIL · 74019P207
|
8.2% |
2/13/2026
Event 12/31/2025
|
|||
| Bleichroeder LP | 8.2% | ||||
| Bleichroeder Holdings LLC | 8.2% | ||||
| Andrew Gundlach | 8.2% | ||||
|
Cellectar Biosciences, Inc.
13G/A
Amendment 1
CLRB · 15117F880
|
4.6% |
2/13/2026
Event 12/31/2025
|
|||
| Bleichroeder LP | 4.6% | ||||
| Bleichroeder Holdings LLC | 4.6% | ||||
| Andrew Gundlach | 4.6% | ||||
|
Scientific Industries, Inc.
13D/A
Amendment 4
SCND · 808757108
|
21.2% |
11/14/2025
Event 9/30/2025
|
|||
| Bleichroeder LP | 21.2% | ||||
| Bleichroeder Holdings LLC | 21.2% | ||||
| Andrew Gundlach | 21.2% | ||||
|
Fluent, Inc.
13G
FLNT · 34380C201
|
9.6% |
11/14/2025
Event 9/30/2025
|
|||
| Bleichroeder LP | 9.6% | ||||
| Bleichroeder Holdings LLC | 9.6% | ||||
| Andrew Gundlach | 9.6% | ||||
|
Cellectar Biosciences, Inc.
13G
CLRB · 15117F880
|
6.1% |
11/14/2025
Event 9/30/2025
|
|||
| Bleichroeder LP | 6.1% | ||||
| Bleichroeder Holdings LLC | 6.1% | ||||
| Andrew Gundlach | 6.1% | ||||
|
SmartKem, Inc.
13G/A
Amendment 2
SMTK · 83193D203
|
4.1% |
11/14/2025
Event 9/30/2025
|
|||
| Bleichroeder LP | 4.1% | ||||
| Bleichroeder Holdings LLC | 4.1% | ||||
| Andrew Gundlach | 4.1% | ||||
|
Aptose Biosciences Inc.
13G/A
Amendment 4
APTO · 03835T309
|
1.6% |
8/14/2025
Event 6/30/2025
|
|||
| Bleichroeder LP | 1.6% | ||||
| Bleichroeder Holdings LLC | 1.6% | ||||
| Andrew Gundlach | 1.6% | ||||
|
Neuroone Medical Technologies Ord
13G
NMTC · 64130M209
|
8.0% |
8/14/2025
Event 6/30/2025
|
|||
| Bleichroeder LP | 8.0% | ||||
| Bleichroeder Holdings LLC | 8.0% | ||||
| Andew Gundlach | 8.0% | ||||
|
SmartKem, Inc.
13G/A
Amendment 1
SMTK · 83193D203
|
5.0% |
8/14/2025
Event 6/30/2025
|
|||
| Bleichroeder LP | 5.0% | ||||
| Bleichroeder Holdings LLC | 5.0% | ||||
| Andrew Gundlach | 5.0% | ||||
|
Precision Biosciences Inc
13G
DTIL · 74019P207
|
9.7% |
8/14/2025
Event 6/30/2025
|
|||
| Bleichroeder LP | 9.7% | ||||
| Bleichroeder Holdings LLC | 9.7% | ||||
| Andrew Gundlach | 9.7% | ||||
|
First Eagle Real Estate Debt Fund
13D/A
Amendment 3
32009F100
|
99.0% |
8/8/2025
Event 8/6/2025
|
|||
| Bleichroeder LP | 99.0% | ||||
| Bleichroeder Holdings LLC | 99.0% | ||||
| Andrew Gundlach | 99.0% | ||||
|
Aptose Biosciences Inc.
13G/A
Amendment 3
APTO · 03835T309
|
6.3% |
5/13/2025
Event 3/31/2025
|
|||
| Bleichroeder LP | 6.3% | ||||
| Bleichroeder Holdings LLC | 6.3% | ||||
| Andrew Gundlach | 6.3% | ||||
|
First Eagle Real Estate Debt Fund
13D/A
Amendment 2
32009F100
|
99.5% |
5/2/2025
Event 4/30/2025
|
|||
| Bleichroeder LP | 99.5% | ||||
| Bleichroeder Holdings LLC | 99.5% | ||||
| Andrew Gundlach | 99.5% | ||||
|
Scientific Industries, Inc.
13D/A
Amendment 3
SCND · 808757108
|
22.7% |
4/22/2025
Event 4/18/2025
|
|||
| Bleichroeder LP | 22.7% | ||||
| Bleichroeder Holdings LLC | 22.7% | ||||
| Andrew Gundlach | 22.7% | ||||
|
First Eagle Real Estate Debt Fund
13D/A
Amendment 1
32009F100
|
99.0% |
4/7/2025
Event 3/31/2025
|
|||
| Bleichroeder LP | 99.0% | ||||
| Bleichroeder Holdings LLC | 99.0% | ||||
| Andrew Gundlach | 99.0% | ||||
|
First Eagle Real Estate Debt Fund
13D
32009F100
|
99.0% |
4/7/2025
Event 3/31/2025
|
|||
| Bleichroeder LP | 99.0% | ||||
| Bleichroeder Holdings LLC | 99.0% | ||||
| Andrew Gundlach | 99.0% | ||||
|
SmartKem, Inc.
13G
SMTK · 83193D203
|
8.9% |
3/31/2025
Event 2/15/2025
|
|||
| Bleichroeder LP | 8.9% | ||||
| Bleichroeder Holdings LLC | 8.9% | ||||
| Andrew Gundlach | 8.9% | ||||
|
Curis Inc
13G
CRIS · 231269309
|
9.9% |
3/31/2025
Event 3/31/2025
|
|||
| Bleichroeder LP | 9.9% | ||||
| Bleichroeder Holdings LLC | 9.9% | ||||
| Andrew Gundlach | 9.9% | ||||
|
LiqTech International, Inc.
13D/A
Amendment 2
LIQT · 53632A201
|
33.7% |
3/28/2025
Event 3/26/2025
|
|||
| Bleichroeder LP | 33.7% | ||||
| Bleichroeder Holdings LLC | 33.7% | ||||
| Andrew Gundlach | 33.7% | ||||
|
Aptose Biosciences Inc.
13G/A
Amendment 2
APTO · 03835T309
|
7.5% |
3/24/2025
Event 3/24/2025
|
|||
| Bleichroeder LP | 7.5% | ||||
| Bleichroeder Holdings LLC | 7.5% | ||||
| Andrew Gundlach | 7.5% | ||||
|
Evoke Pharma, Inc.
13G/A
Amendment 3
EVOK · 30049G203
|
10.0% |
3/24/2025
Event 3/24/2025
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
Barfresh Food Group Inc.
13G/A
Amendment 5
BRFH · 067532200
|
8.8% |
3/24/2025
Event 3/24/2025
|
|||
| Bleichroeder LP | 8.8% | ||||
| Bleichroeder Holdings LLC | 8.8% | ||||
| Andrew Gundlach | 8.8% | ||||
|
MDxHealth SA
13G/A
Amendment 6
MDXH · 58286E102
|
15.0% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 15.0% | ||||
| Bleichroeder Holdings LLC | 15.0% | ||||
| Andrew Gundlach | 15.0% | ||||
|
Intevac, Inc.
13G/A
Amendment 5
IVAC · 461148108
|
19.1% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 19.1% | ||||
| Bleichroeder Holdings LLC | 19.1% | ||||
| Andrew Gundlach | 19.1% | ||||
|
Intellicheck, Inc.
13G/A
Amendment 4
IDN · 45817G201
|
11.1% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 11.1% | ||||
| Bleichroeder Holdings LLC | 11.1% | ||||
| Andrew Gundlach | 11.1% | ||||
|
Guerrilla RF, Inc.
13G/A
Amendment 1
GUER · 40162G203
|
7.7% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 7.7% | ||||
| Bleichroeder Holdings LLC | 7.7% | ||||
| Andrew Gundlach | 7.7% | ||||
|
Evoke Pharma, Inc.
13G/A
Amendment 2
EVOK · 30049G203
|
10.0% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
Duos Technologies Group, Inc.
13G/A
Amendment 8
DUOT · 266042407
|
20.0% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 20.0% | ||||
| Bleichroeder Holdings LLC | 20.0% | ||||
| Andrew Gundlach | 20.0% | ||||
|
Cue Biopharma, Inc.
13G/A
Amendment 2
CUE · 22978P106
|
10.0% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
| Andrew Gundlach | 10.0% | ||||
|
Barfresh Food Group Inc.
13G/A
Amendment 4
BRFH · 067532200
|
8.3% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 8.3% | ||||
| Bleichroeder Holdings LLC | 8.3% | ||||
| Andrew Gundlach | 8.3% | ||||
|
Aptose Biosciences Inc.
13G/A
Amendment 1
APTO · 03835T309
|
6.2% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 6.2% | ||||
| Bleichroeder Holdings LLC | 6.2% | ||||
| Andrew Gundlach | 6.2% | ||||
|
Scientific Industries, Inc.
13D/A
Amendment 2
SCND · 808757108
|
21.0% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 21.0% | ||||
| Bleichroeder Holdings LLC | 21.0% | ||||
| Andrew Gundlach | 21.0% | ||||
|
LiqTech International, Inc.
13D/A
Amendment 1
LIQT · 53632A201
|
33.7% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 33.7% | ||||
| Bleichroeder Holdings LLC | 33.7% | ||||
| Andrew Gundlach | 33.7% | ||||
|
Identiv, Inc. (INVE)
13D/A
Amendment 4
INVE · 45170X205
|
19.9% |
3/21/2025
Event 3/19/2025
|
|||
| Bleichroeder LP | 19.9% | ||||
| Bleichroeder Holdings LLC | 19.9% | ||||
| Andrew Gundlach | 19.9% | ||||
|
MDxHealth SA
13G/A
Amendment 5
MDXH · 58286E102
|
14.9% |
2/13/2025
Event 12/31/2024
|
|||
| Bleichroeder LP | 14.9% | ||||
| Bleichroeder Holdings LLC | 14.9% | ||||
|
Aptose Biosciences Inc.
13G
APTO · 03835T309
|
6.2% |
2/13/2025
Event 12/31/2024
|
|||
| Bleichroeder LP | 6.2% | ||||
| Bleichroeder Holdings LLC | 6.2% | ||||
|
Cue Biopharma, Inc.
13G/A
Amendment 1
CUE · 22978P106
|
10.0% |
10/7/2024
Event 9/30/2024
|
|||
| Bleichroeder LP | 10.0% | ||||
| Bleichroeder Holdings LLC | 10.0% | ||||
|
MDxHealth SA
13G/A
Amendment 4
MDXH · 58286E102
|
17.7% |
10/3/2024
Event 9/30/2024
|
|||
| Bleichroeder LP | 17.7% | ||||
| Bleichroeder Holdings LLC | 17.7% | ||||
|
CompoSecure, Inc.
13G/A
Amendment 3
GPGI · 20459V105
|
4.7% |
10/3/2024
Event 9/30/2024
|
|||
| Bleichroeder LP | 4.7% | ||||
| Bleichroeder Holdings LLC | 4.7% | ||||